Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 200 of 517 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/13
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/28/19
End: 10/10/19
Due: 10/10/20
Phase: N/A
Priority: Normal
Start: 05/23/23
End: 10/20/23
Due: 10/20/24
Phase: N/A
Priority: Normal
Start: 03/04/21
End: 07/22/22
Due: 07/22/23
Phase: N/A
Priority: Normal
Start: 04/30/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 04/24/21
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 08/16/19
End: 07/31/22
Due: 07/31/23
Phase: N/A
Priority: Normal
Start: 08/11/22
End: 12/16/22
Due: 12/16/23
Phase: N/A
Priority: Normal
Start: 12/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/06/22
End: 05/11/22
Due: 05/11/23
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 10/31/13
Due: 10/31/14
The Relative Bioavailability of INS068 Injection With Two Different Formulations in Healthy Subjects
Phase: N/A
Priority: Normal
Start: 05/12/22
End: 06/02/22
Due: 06/02/23
Phase: N/A
Priority: Normal
Start: 04/06/16
End: 11/17/19
Due: 11/17/20
Phase: N/A
Priority: Normal
Start: 08/04/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 04/30/23
End: 12/30/26
Due: 12/30/27
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 04/08/21
End: 06/28/24
Due: 06/28/25
Phase: N/A
Priority: Normal
Start: 04/07/20
End: 11/30/20
Due: 11/30/21
Phase: N/A
Priority: Normal
Start: 04/30/25
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 09/21/20
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 11/10/20
End: 03/01/25
Due: 03/01/26
Phase: N/A
Priority: Normal
Start: 04/23/21
End: 01/06/22
Due: 01/06/23
Phase: N/A
Priority: Normal
Start: 04/01/21
End: 07/31/24
Due: 07/31/25